Review



rabbit polyclonal antibody against abca1  (Novus Biologicals)


Bioz Verified Symbol Novus Biologicals is a verified supplier
Bioz Manufacturer Symbol Novus Biologicals manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Novus Biologicals rabbit polyclonal antibody against abca1
    Figure 2. Treatment using LXR/RXR ligands does not lead to an increase in the endogenous <t>ABCA1</t> or ARL4C level in many cell lines: (A) Titration of BS-C-1 lysate demonstrates that the ratio of levels of ARL4C in Vero and BS-C-1 cells is 1:4.5. (B) The level of ARL4C is not increased in both Vero and BS-C-1 cells even after 7 days of treatment with T0901317 and bexarotene. (C) LXR/RXR-dependent pathway is activated in HeLa cells and weakly activated in MCF7 cells after 48h exposure to 2.5 µM T0901317/bexarotene; however, not in Vero cells even after prolonged treatment. (D) Neither ABCA1 nor ARL4C levels increase after treatment of COS7 and U2OS cells with RXR/LXR ligands. Long-term treatment of the MCF7 cells results in only a slight increase in the ARL4C level.
    Rabbit Polyclonal Antibody Against Abca1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 130 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal antibody against abca1/product/Novus Biologicals
    Average 94 stars, based on 130 article reviews
    rabbit polyclonal antibody against abca1 - by Bioz Stars, 2026-05
    94/100 stars

    Images

    1) Product Images from "Small GTPase ARL4C Associated with Various Cancers Affects Microtubule Nucleation."

    Article Title: Small GTPase ARL4C Associated with Various Cancers Affects Microtubule Nucleation.

    Journal: Biomedicines

    doi: 10.3390/biomedicines12122872

    Figure 2. Treatment using LXR/RXR ligands does not lead to an increase in the endogenous ABCA1 or ARL4C level in many cell lines: (A) Titration of BS-C-1 lysate demonstrates that the ratio of levels of ARL4C in Vero and BS-C-1 cells is 1:4.5. (B) The level of ARL4C is not increased in both Vero and BS-C-1 cells even after 7 days of treatment with T0901317 and bexarotene. (C) LXR/RXR-dependent pathway is activated in HeLa cells and weakly activated in MCF7 cells after 48h exposure to 2.5 µM T0901317/bexarotene; however, not in Vero cells even after prolonged treatment. (D) Neither ABCA1 nor ARL4C levels increase after treatment of COS7 and U2OS cells with RXR/LXR ligands. Long-term treatment of the MCF7 cells results in only a slight increase in the ARL4C level.
    Figure Legend Snippet: Figure 2. Treatment using LXR/RXR ligands does not lead to an increase in the endogenous ABCA1 or ARL4C level in many cell lines: (A) Titration of BS-C-1 lysate demonstrates that the ratio of levels of ARL4C in Vero and BS-C-1 cells is 1:4.5. (B) The level of ARL4C is not increased in both Vero and BS-C-1 cells even after 7 days of treatment with T0901317 and bexarotene. (C) LXR/RXR-dependent pathway is activated in HeLa cells and weakly activated in MCF7 cells after 48h exposure to 2.5 µM T0901317/bexarotene; however, not in Vero cells even after prolonged treatment. (D) Neither ABCA1 nor ARL4C levels increase after treatment of COS7 and U2OS cells with RXR/LXR ligands. Long-term treatment of the MCF7 cells results in only a slight increase in the ARL4C level.

    Techniques Used: Titration



    Similar Products

    94
    Novus Biologicals rabbit polyclonal antibody against abca1
    Figure 2. Treatment using LXR/RXR ligands does not lead to an increase in the endogenous <t>ABCA1</t> or ARL4C level in many cell lines: (A) Titration of BS-C-1 lysate demonstrates that the ratio of levels of ARL4C in Vero and BS-C-1 cells is 1:4.5. (B) The level of ARL4C is not increased in both Vero and BS-C-1 cells even after 7 days of treatment with T0901317 and bexarotene. (C) LXR/RXR-dependent pathway is activated in HeLa cells and weakly activated in MCF7 cells after 48h exposure to 2.5 µM T0901317/bexarotene; however, not in Vero cells even after prolonged treatment. (D) Neither ABCA1 nor ARL4C levels increase after treatment of COS7 and U2OS cells with RXR/LXR ligands. Long-term treatment of the MCF7 cells results in only a slight increase in the ARL4C level.
    Rabbit Polyclonal Antibody Against Abca1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal antibody against abca1/product/Novus Biologicals
    Average 94 stars, based on 1 article reviews
    rabbit polyclonal antibody against abca1 - by Bioz Stars, 2026-05
    94/100 stars
      Buy from Supplier

    94
    Novus Biologicals polyclonal rabbit anti mouse abca1
    Pparα deficiency in intestinal epithelium increases the translocation of gut-derived antigens into the liver. (A) Intestinal permeability assessment (FITC-dextran, 4 kD) in 8-week-old mice ( n = 10). (B) Relative mRNA levels of Zo-1 and Cldn8 in the ileum from 8-week-old mice ( n = 5). (C) The relative proportion of bacterial species in the cecum content by 16S rRNA gene sequencing ( n = 6). (D) Bugbase phenotypic prediction of gut microbiota in 8-week-old mice ( n = 6). (E) The mRNA and protein levels of PV1 in the ileum of 8-week-old mice ( n = 5). (F) Transmission electron microscopy images of the diaphragm (red star) in the capillaries from ileum sections in 24-week-old mice ( n = 3). (G) Representative images of fluorescence microscopy and transmission electron in 8-week-old mice treated with FITC-LPS (green) or Au-LPS ( n = 3–5). (H) Portal HDL-C levels in 8-week-old mice ( n = 10). (I) The protein levels of APOA1 and <t>ABCA1</t> in the ileum of 8-week-old mice ( n = 5). (J) Relative mRNA levels of Apoa1 , Pon1 , and Pon3 in the ileum of 8-week-old mice ( n = 5). (K) Serum APOA1 levels in 8-, 16- and 32-week-old mice ( n = 8–10). (L) Serum APOA1 levels in 8-week-old mice exposed to HFCS for 14 days ( n = 8). (M) Serum APOA1 levels in 16-week-old Pparα Δhep mice ( n = 10). (N) Schematic representation of a cocktail of broad-spectrum antibiotics (Abx) experimental design. (O) Representative images stained with H&E and Oil Red O, and immunofluorescent staining for F4/80 (red) in the liver from 8-week-old mice treated with Abx ( n = 5). (P) Triglyceride in serum and liver treated with Abx ( n = 10). (Q) Relative mRNA levels of genes related to triglyceride accumulation in the liver from 8-week-old mice treated with Abx ( n = 5). (R) Hepatic levels of cytokines from 8-week-old mice treated with Abx ( n = 5). (S) Protein levels of F4/80 in the liver of 8-week-old mice treated with Abx ( n = 3). (T) Relative mRNA levels of F4/80, Clec4f , and Cd14 in the liver of 8-week-old mice treated with Abx ( n = 5). LD: lipid droplet; M: mitochondria; FITC-LPS: fluorescein isothiocyanate (FITC)-LPS; Au-LPS: LPS-gold-complexes. Data are shown as the mean ± SD. An unpaired two-tailed Student's t -test; ∗∗ P < 0.01, ∗∗∗ P < 0.001.
    Polyclonal Rabbit Anti Mouse Abca1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/polyclonal rabbit anti mouse abca1/product/Novus Biologicals
    Average 94 stars, based on 1 article reviews
    polyclonal rabbit anti mouse abca1 - by Bioz Stars, 2026-05
    94/100 stars
      Buy from Supplier

    95
    Proteintech rabbit polyclonal primary antibodies abca1
    Pparα deficiency in intestinal epithelium increases the translocation of gut-derived antigens into the liver. (A) Intestinal permeability assessment (FITC-dextran, 4 kD) in 8-week-old mice ( n = 10). (B) Relative mRNA levels of Zo-1 and Cldn8 in the ileum from 8-week-old mice ( n = 5). (C) The relative proportion of bacterial species in the cecum content by 16S rRNA gene sequencing ( n = 6). (D) Bugbase phenotypic prediction of gut microbiota in 8-week-old mice ( n = 6). (E) The mRNA and protein levels of PV1 in the ileum of 8-week-old mice ( n = 5). (F) Transmission electron microscopy images of the diaphragm (red star) in the capillaries from ileum sections in 24-week-old mice ( n = 3). (G) Representative images of fluorescence microscopy and transmission electron in 8-week-old mice treated with FITC-LPS (green) or Au-LPS ( n = 3–5). (H) Portal HDL-C levels in 8-week-old mice ( n = 10). (I) The protein levels of APOA1 and <t>ABCA1</t> in the ileum of 8-week-old mice ( n = 5). (J) Relative mRNA levels of Apoa1 , Pon1 , and Pon3 in the ileum of 8-week-old mice ( n = 5). (K) Serum APOA1 levels in 8-, 16- and 32-week-old mice ( n = 8–10). (L) Serum APOA1 levels in 8-week-old mice exposed to HFCS for 14 days ( n = 8). (M) Serum APOA1 levels in 16-week-old Pparα Δhep mice ( n = 10). (N) Schematic representation of a cocktail of broad-spectrum antibiotics (Abx) experimental design. (O) Representative images stained with H&E and Oil Red O, and immunofluorescent staining for F4/80 (red) in the liver from 8-week-old mice treated with Abx ( n = 5). (P) Triglyceride in serum and liver treated with Abx ( n = 10). (Q) Relative mRNA levels of genes related to triglyceride accumulation in the liver from 8-week-old mice treated with Abx ( n = 5). (R) Hepatic levels of cytokines from 8-week-old mice treated with Abx ( n = 5). (S) Protein levels of F4/80 in the liver of 8-week-old mice treated with Abx ( n = 3). (T) Relative mRNA levels of F4/80, Clec4f , and Cd14 in the liver of 8-week-old mice treated with Abx ( n = 5). LD: lipid droplet; M: mitochondria; FITC-LPS: fluorescein isothiocyanate (FITC)-LPS; Au-LPS: LPS-gold-complexes. Data are shown as the mean ± SD. An unpaired two-tailed Student's t -test; ∗∗ P < 0.01, ∗∗∗ P < 0.001.
    Rabbit Polyclonal Primary Antibodies Abca1, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal primary antibodies abca1/product/Proteintech
    Average 95 stars, based on 1 article reviews
    rabbit polyclonal primary antibodies abca1 - by Bioz Stars, 2026-05
    95/100 stars
      Buy from Supplier

    95
    Cell Signaling Technology Inc rabbit polyclonal anti abca1

    Rabbit Polyclonal Anti Abca1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti abca1/product/Cell Signaling Technology Inc
    Average 95 stars, based on 1 article reviews
    rabbit polyclonal anti abca1 - by Bioz Stars, 2026-05
    95/100 stars
      Buy from Supplier

    95
    Novus Biologicals rabbit polyclonal anti abca1

    Rabbit Polyclonal Anti Abca1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti abca1/product/Novus Biologicals
    Average 95 stars, based on 1 article reviews
    rabbit polyclonal anti abca1 - by Bioz Stars, 2026-05
    95/100 stars
      Buy from Supplier

    86
    Danaher Inc rabbit polyclonal anti abca1 transporter

    Rabbit Polyclonal Anti Abca1 Transporter, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti abca1 transporter/product/Danaher Inc
    Average 86 stars, based on 1 article reviews
    rabbit polyclonal anti abca1 transporter - by Bioz Stars, 2026-05
    86/100 stars
      Buy from Supplier

    94
    Santa Cruz Biotechnology rabbit polyclonal abca1

    Rabbit Polyclonal Abca1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal abca1/product/Santa Cruz Biotechnology
    Average 94 stars, based on 1 article reviews
    rabbit polyclonal abca1 - by Bioz Stars, 2026-05
    94/100 stars
      Buy from Supplier

    Image Search Results


    Figure 2. Treatment using LXR/RXR ligands does not lead to an increase in the endogenous ABCA1 or ARL4C level in many cell lines: (A) Titration of BS-C-1 lysate demonstrates that the ratio of levels of ARL4C in Vero and BS-C-1 cells is 1:4.5. (B) The level of ARL4C is not increased in both Vero and BS-C-1 cells even after 7 days of treatment with T0901317 and bexarotene. (C) LXR/RXR-dependent pathway is activated in HeLa cells and weakly activated in MCF7 cells after 48h exposure to 2.5 µM T0901317/bexarotene; however, not in Vero cells even after prolonged treatment. (D) Neither ABCA1 nor ARL4C levels increase after treatment of COS7 and U2OS cells with RXR/LXR ligands. Long-term treatment of the MCF7 cells results in only a slight increase in the ARL4C level.

    Journal: Biomedicines

    Article Title: Small GTPase ARL4C Associated with Various Cancers Affects Microtubule Nucleation.

    doi: 10.3390/biomedicines12122872

    Figure Lengend Snippet: Figure 2. Treatment using LXR/RXR ligands does not lead to an increase in the endogenous ABCA1 or ARL4C level in many cell lines: (A) Titration of BS-C-1 lysate demonstrates that the ratio of levels of ARL4C in Vero and BS-C-1 cells is 1:4.5. (B) The level of ARL4C is not increased in both Vero and BS-C-1 cells even after 7 days of treatment with T0901317 and bexarotene. (C) LXR/RXR-dependent pathway is activated in HeLa cells and weakly activated in MCF7 cells after 48h exposure to 2.5 µM T0901317/bexarotene; however, not in Vero cells even after prolonged treatment. (D) Neither ABCA1 nor ARL4C levels increase after treatment of COS7 and U2OS cells with RXR/LXR ligands. Long-term treatment of the MCF7 cells results in only a slight increase in the ARL4C level.

    Article Snippet: Then, the membrane was blocked with 5% skimmed milk in TBST for 1 h. Rabbit polyclonal antibody against ARL4C (Novus Biologicals, Centennial, CO, USA), mouse monoclonal antibody against GAPDH (ThermoFisher Scientific, Waltham, MA, USA), rabbit polyclonal antibody against ABCA1 (Novus Biologicals, Centennial, CO, USA), mouse monoclonal antibody against α-tubulin, and clone DM1A (Santa Cruz Biotechnology, Dallas, TX, USA) were used as primary antibodies.

    Techniques: Titration

    Pparα deficiency in intestinal epithelium increases the translocation of gut-derived antigens into the liver. (A) Intestinal permeability assessment (FITC-dextran, 4 kD) in 8-week-old mice ( n = 10). (B) Relative mRNA levels of Zo-1 and Cldn8 in the ileum from 8-week-old mice ( n = 5). (C) The relative proportion of bacterial species in the cecum content by 16S rRNA gene sequencing ( n = 6). (D) Bugbase phenotypic prediction of gut microbiota in 8-week-old mice ( n = 6). (E) The mRNA and protein levels of PV1 in the ileum of 8-week-old mice ( n = 5). (F) Transmission electron microscopy images of the diaphragm (red star) in the capillaries from ileum sections in 24-week-old mice ( n = 3). (G) Representative images of fluorescence microscopy and transmission electron in 8-week-old mice treated with FITC-LPS (green) or Au-LPS ( n = 3–5). (H) Portal HDL-C levels in 8-week-old mice ( n = 10). (I) The protein levels of APOA1 and ABCA1 in the ileum of 8-week-old mice ( n = 5). (J) Relative mRNA levels of Apoa1 , Pon1 , and Pon3 in the ileum of 8-week-old mice ( n = 5). (K) Serum APOA1 levels in 8-, 16- and 32-week-old mice ( n = 8–10). (L) Serum APOA1 levels in 8-week-old mice exposed to HFCS for 14 days ( n = 8). (M) Serum APOA1 levels in 16-week-old Pparα Δhep mice ( n = 10). (N) Schematic representation of a cocktail of broad-spectrum antibiotics (Abx) experimental design. (O) Representative images stained with H&E and Oil Red O, and immunofluorescent staining for F4/80 (red) in the liver from 8-week-old mice treated with Abx ( n = 5). (P) Triglyceride in serum and liver treated with Abx ( n = 10). (Q) Relative mRNA levels of genes related to triglyceride accumulation in the liver from 8-week-old mice treated with Abx ( n = 5). (R) Hepatic levels of cytokines from 8-week-old mice treated with Abx ( n = 5). (S) Protein levels of F4/80 in the liver of 8-week-old mice treated with Abx ( n = 3). (T) Relative mRNA levels of F4/80, Clec4f , and Cd14 in the liver of 8-week-old mice treated with Abx ( n = 5). LD: lipid droplet; M: mitochondria; FITC-LPS: fluorescein isothiocyanate (FITC)-LPS; Au-LPS: LPS-gold-complexes. Data are shown as the mean ± SD. An unpaired two-tailed Student's t -test; ∗∗ P < 0.01, ∗∗∗ P < 0.001.

    Journal: Acta Pharmaceutica Sinica. B

    Article Title: PPAR α affects hepatic lipid homeostasis by perturbing necroptosis signals in the intestinal epithelium

    doi: 10.1016/j.apsb.2024.08.021

    Figure Lengend Snippet: Pparα deficiency in intestinal epithelium increases the translocation of gut-derived antigens into the liver. (A) Intestinal permeability assessment (FITC-dextran, 4 kD) in 8-week-old mice ( n = 10). (B) Relative mRNA levels of Zo-1 and Cldn8 in the ileum from 8-week-old mice ( n = 5). (C) The relative proportion of bacterial species in the cecum content by 16S rRNA gene sequencing ( n = 6). (D) Bugbase phenotypic prediction of gut microbiota in 8-week-old mice ( n = 6). (E) The mRNA and protein levels of PV1 in the ileum of 8-week-old mice ( n = 5). (F) Transmission electron microscopy images of the diaphragm (red star) in the capillaries from ileum sections in 24-week-old mice ( n = 3). (G) Representative images of fluorescence microscopy and transmission electron in 8-week-old mice treated with FITC-LPS (green) or Au-LPS ( n = 3–5). (H) Portal HDL-C levels in 8-week-old mice ( n = 10). (I) The protein levels of APOA1 and ABCA1 in the ileum of 8-week-old mice ( n = 5). (J) Relative mRNA levels of Apoa1 , Pon1 , and Pon3 in the ileum of 8-week-old mice ( n = 5). (K) Serum APOA1 levels in 8-, 16- and 32-week-old mice ( n = 8–10). (L) Serum APOA1 levels in 8-week-old mice exposed to HFCS for 14 days ( n = 8). (M) Serum APOA1 levels in 16-week-old Pparα Δhep mice ( n = 10). (N) Schematic representation of a cocktail of broad-spectrum antibiotics (Abx) experimental design. (O) Representative images stained with H&E and Oil Red O, and immunofluorescent staining for F4/80 (red) in the liver from 8-week-old mice treated with Abx ( n = 5). (P) Triglyceride in serum and liver treated with Abx ( n = 10). (Q) Relative mRNA levels of genes related to triglyceride accumulation in the liver from 8-week-old mice treated with Abx ( n = 5). (R) Hepatic levels of cytokines from 8-week-old mice treated with Abx ( n = 5). (S) Protein levels of F4/80 in the liver of 8-week-old mice treated with Abx ( n = 3). (T) Relative mRNA levels of F4/80, Clec4f , and Cd14 in the liver of 8-week-old mice treated with Abx ( n = 5). LD: lipid droplet; M: mitochondria; FITC-LPS: fluorescein isothiocyanate (FITC)-LPS; Au-LPS: LPS-gold-complexes. Data are shown as the mean ± SD. An unpaired two-tailed Student's t -test; ∗∗ P < 0.01, ∗∗∗ P < 0.001.

    Article Snippet: These samples were incubated overnight with a polyclonal rabbit anti-mouse F4/80 (1:1000, #A1256, ABclonal), polyclonal rabbit anti-mouse APOA1 (1:2000, #A14211, ABclonal), polyclonal rabbit anti-mouse ABCA1 (1:1000, #NB400-105, Novus Biological, Centennial), monoclonal rabbit anti-mouse CD14 (1:1000, #A19011, ABclonal), or polyclonal rabbit anti-mouse PV1 (1:2000, #A15906, ABclonal).

    Techniques: Translocation Assay, Derivative Assay, Permeability, Sequencing, Transmission Assay, Electron Microscopy, Fluorescence, Microscopy, Staining, Two Tailed Test

    Journal: iScience

    Article Title: Alphaherpesvirus manipulates retinoic acid metabolism for optimal replication

    doi: 10.1016/j.isci.2024.110144

    Figure Lengend Snippet:

    Article Snippet: Rabbit polyclonal anti-ABCA1 , Cell Signaling Technology , Cat# 96292.

    Techniques: Recombinant, Transfection, Enzyme-linked Immunosorbent Assay, Plasmid Preparation, Software